Among this cohort of 206 patients, 16 studies included LITT for primary IDH-wild type glioblastoma (N = 185, 90%), while 6 studies reported on LITT for IDH-mutant astrocytoma (N = 21, 10%) (Table 1). Here, IDH1 is linked to glioblastoma.